These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34200577)

  • 1. Circulating Levels of Pro-Neurotensin and Its Relationship with Nonalcoholic Steatohepatitis and Hepatic Lipid Metabolism.
    Villar B; Bertran L; Aguilar C; Binetti J; Martínez S; Sabench F; Real M; Riesco D; París M; Del Castillo D; Richart C; Auguet T
    Metabolites; 2021 Jun; 11(6):. PubMed ID: 34200577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low Circulating Levels of Neurotensin in Women with Nonalcoholic Fatty Liver Disease Associated with Severe Obesity.
    Auguet T; Aragonès G; Berlanga A; Martínez S; Sabench F; Aguilar C; Villar B; Sirvent JJ; Del Castillo D; Richart C
    Obesity (Silver Spring); 2018 Feb; 26(2):274-278. PubMed ID: 29276861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Hepatic
    Barrientos-Riosalido A; Real M; Bertran L; Aguilar C; Martínez S; Parada D; Vives M; Sabench F; Riesco D; Castillo DD; Richart C; Auguet T
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Plasma Proneurotensin Levels Identify NAFLD in Adults With and Without Type 2 Diabetes.
    Barchetta I; Cimini FA; Leonetti F; Capoccia D; Di Cristofano C; Silecchia G; Orho-Melander M; Melander O; Cavallo MG
    J Clin Endocrinol Metab; 2018 Jun; 103(6):2253-2260. PubMed ID: 29590379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deregulation of Secreted Frizzled-Related Protein 5 in Nonalcoholic Fatty Liver Disease Associated with Obesity.
    Bertran L; Portillo-Carrasquer M; Aguilar C; Porras JA; Riesco D; Martínez S; Vives M; Sabench F; Gonzalez E; Del Castillo D; Richart C; Auguet T
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34198988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Potential Protective Role of RUNX1 in Nonalcoholic Fatty Liver Disease.
    Bertran L; Pastor A; Portillo-Carrasquer M; Binetti J; Aguilar C; Martínez S; Vives M; Sabench F; Porras JA; Riesco D; Del Castillo D; Richart C; Auguet T
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34063472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between IL-8 Circulating Levels and TLR2 Hepatic Expression in Women with Morbid Obesity and Nonalcoholic Steatohepatitis.
    Auguet T; Bertran L; Binetti J; Aguilar C; Martínez S; Sabench F; Lopez-Dupla JM; Porras JA; Riesco D; Del Castillo D; Richart C
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32545403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR33a/miR33b* and miR122 as Possible Contributors to Hepatic Lipid Metabolism in Obese Women with Nonalcoholic Fatty Liver Disease.
    Auguet T; Aragonès G; Berlanga A; Guiu-Jurado E; Martí A; Martínez S; Sabench F; Hernández M; Aguilar C; Sirvent JJ; Del Castillo D; Richart C
    Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of STING in Women with Morbid Obesity and Nonalcoholic Fatty Liver Disease.
    Bertran L; Adalid L; Vilaró-Blay M; Barrientos-Riosalido A; Aguilar C; Martínez S; Sabench F; Del Castillo D; Porras JA; Alibalic A; Richart C; Auguet T
    Metabolites; 2023 Mar; 13(4):. PubMed ID: 37110154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher circulating levels of proneurotensin are associated with increased risk of incident NAFLD.
    De Vito F; Cassano V; Mancuso E; Succurro E; Hribal ML; Sciacqua A; Andreozzi F; Sesti G; Fiorentino TV
    J Intern Med; 2023 Sep; 294(3):336-346. PubMed ID: 37157165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocannabinoid receptors gene expression in morbidly obese women with nonalcoholic fatty liver disease.
    Auguet T; Berlanga A; Guiu-Jurado E; Terra X; Martinez S; Aguilar C; Filiu E; Alibalic A; Sabench F; Hernández M; Del Castillo D; Richart C
    Biomed Res Int; 2014; 2014():502542. PubMed ID: 24864249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Olfactomedin 2 in the Adipose Tissue-Liver Axis and Its Implication in Obesity-Associated Nonalcoholic Fatty Liver Disease.
    Barrientos-Riosalido A; Bertran L; Vilaró-Blay M; Aguilar C; Martínez S; Paris M; Sabench F; Riesco D; Binetti J; Castillo DD; Richart C; Auguet T
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating microbiota-derived metabolites: a "liquid biopsy?
    Aragonès G; Colom-Pellicer M; Aguilar C; Guiu-Jurado E; Martínez S; Sabench F; Antonio Porras J; Riesco D; Del Castillo D; Richart C; Auguet T
    Int J Obes (Lond); 2020 Apr; 44(4):875-885. PubMed ID: 31388096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
    Suppli MP; Rigbolt KTG; Veidal SS; Heebøll S; Eriksen PL; Demant M; Bagger JI; Nielsen JC; Oró D; Thrane SW; Lund A; Strandberg C; Kønig MJ; Vilsbøll T; Vrang N; Thomsen KL; Grønbæk H; Jelsing J; Hansen HH; Knop FK
    Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G462-G472. PubMed ID: 30653341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of serum retinoic acid with hepatic steatosis and liver injury in nonalcoholic fatty liver disease.
    Liu Y; Chen H; Wang J; Zhou W; Sun R; Xia M
    Am J Clin Nutr; 2015 Jul; 102(1):130-7. PubMed ID: 25948673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepcidin in morbidly obese women with non-alcoholic fatty liver disease.
    Auguet T; Aragonès G; Berlanga A; Martínez S; Sabench F; Binetti J; Aguilar C; Porras JA; Molina A; Del Castillo D; Richart C
    PLoS One; 2017; 12(10):e0187065. PubMed ID: 29065180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deregulated Serotonin Pathway in Women with Morbid Obesity and NAFLD.
    Binetti J; Bertran L; Riesco D; Aguilar C; Martínez S; Sabench F; Porras JA; Camaron J; Castillo DD; Richart C; Auguet T
    Life (Basel); 2020 Oct; 10(10):. PubMed ID: 33081272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered fatty acid metabolism-related gene expression in liver from morbidly obese women with non-alcoholic fatty liver disease.
    Auguet T; Berlanga A; Guiu-Jurado E; Martinez S; Porras JA; Aragonès G; Sabench F; Hernandez M; Aguilar C; Sirvent JJ; Del Castillo D; Richart C
    Int J Mol Sci; 2014 Dec; 15(12):22173-87. PubMed ID: 25474087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic lipidomic remodeling in severe obesity manifests with steatosis and does not evolve with non-alcoholic steatohepatitis.
    Ooi GJ; Meikle PJ; Huynh K; Earnest A; Roberts SK; Kemp W; Parker BL; Brown W; Burton P; Watt MJ
    J Hepatol; 2021 Sep; 75(3):524-535. PubMed ID: 33887358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma phospholipids and fatty acid composition differ between liver biopsy-proven nonalcoholic fatty liver disease and healthy subjects.
    Ma DW; Arendt BM; Hillyer LM; Fung SK; McGilvray I; Guindi M; Allard JP
    Nutr Diabetes; 2016 Jul; 6(7):e220. PubMed ID: 27428872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.